Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes
M Kobayashi, N Abiru, T Arakawa, K Fukushima, H Zhou, E Kawasaki, H Yamasaki, E Liu, D Miao, FS Wong, GS Eisenbarth, K Eguchi
Research output: Contribution to journal › Article (Academic Journal) › peer-review
36Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes'. Together they form a unique fingerprint.